
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2023年年度报告 | 2024-04-29 | Chinese | |
| 2023年度独立董事述职报告(梅婷) | 2024-04-29 | Chinese | |
| 关于计提2023年度资产减值准备的公告 | 2024-04-29 | Chinese | |
| 2024年第一季度报告 | 2024-04-29 | Chinese | |
| 关于2024年度使用闲置自有资金进行委托理财预计的公告 | 2024-04-29 | Chinese | |
| 2023年度独立董事述职报告(包满珠) | 2024-04-29 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 38193435 | 2023年年度报告 | 2024-04-29 | Chinese | ||
| 38193431 | 2023年度独立董事述职报告(梅婷) | 2024-04-29 | Chinese | ||
| 38193415 | 关于计提2023年度资产减值准备的公告 | 2024-04-29 | Chinese | ||
| 38193398 | 2024年第一季度报告 | 2024-04-29 | Chinese | ||
| 38193381 | 关于2024年度使用闲置自有资金进行委托理财预计的公告 | 2024-04-29 | Chinese | ||
| 38193363 | 2023年度独立董事述职报告(包满珠) | 2024-04-29 | Chinese | ||
| 38193350 | 第四届监事会第二十二次会议决议公告 | 2024-04-29 | Chinese | ||
| 38193337 | 天域生态环境股份有限公司2023年度募集资金存放与实际使用情况的专项鉴证报告 | 2024-04-29 | Chinese | ||
| 38193219 | 天域生态环境股份有限公司2023年度内部控制审计报告 | 2024-04-29 | Chinese | ||
| 38193170 | 2023年度内部控制评价报告 | 2024-04-29 | Chinese | ||
| 38193143 | 关于公司2024年度对外担保预计的公告 | 2024-04-29 | Chinese | ||
| 38193127 | 天域生态环境股份有限公司2023年度非经营性资金占用及其他关联资金往来情况的专项说明 | 2024-04-29 | Chinese | ||
| 38193061 | 天域生态环境股份有限公司 2023年度财务报表及审计报告 | 2024-04-29 | Chinese | ||
| 38191878 | 关于天域生态环境股份有限公司2023年度营业收入扣除情况的专项审核报告 | 2024-04-29 | Chinese | ||
| 38191786 | 关于公司2023年度利润分配预案的公告 | 2024-04-29 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.